Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolation rabbit heart

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 3, 1996, Pages 579-588

  Wang, Peipei ^a   Gallagher, Kim P ^b   Downey, James M ^a   Cohen, Michael V ^a,c  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

8 (p Sulfophenyl)theophylline; Adenosine; Chelerythrine; Endothelin 1; Ischemic preconditioning; PD 156 707; Protein kinase C

Indexed keywords

ORYCTOLAGUS CUNICULUS; ANIMALIA;

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CHELERYTHRINE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; NICARDIPINE; PROTEIN KINASE C; TRIPHENYLTETRAZOLIUM;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME ACTIVATION; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION;

ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CORONARY VESSELS; DIOXOLES; ENDOTHELIN-1; FEMALE; HEART; HEMODYNAMIC PROCESSES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; PHENANTHRIDINES; PROTEIN KINASE C; RABBITS; RECEPTORS, ENDOTHELIN; RECEPTORS, PURINERGIC P1; THEOPHYLLINE;

EID: 0029987782     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0054     Document Type: Article

References (46)

1. ARMSTRONG S, DOWNEY JM, GANOTE CE, 1994. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 28: 72-77.
2. B) mediate vasoconstriction in the perfused rat heart. J Cardiovasc Pharmacol 22 [Suppl. 8]: S248-S251.
3. BOGOYEVITCH MA, PARKER PJ, SUGDEN PH, 1993. Characterization of protein kinase C isotype expression in adult rat heart: protein kinase C-ε is a major isotype present, and it is activated by phorbol esters, epinephrine, and endothelin. Circ Res 72: 757-767.
4. BREW EC, MITCHELL MB, REHRING TF, GAMBONI-ROBERTSON F, MCINTYRE RC JR, HARKEN AH, BANERJEE A, 1995. Role of bradykinin in cardiac functional protection after global ischemia-reperfusion in rat heart. Am J Physiol269 H1370-H1378.
5. CAVE AC, APSTEIN CS, 1994. Inhibition of protein kinase C abolishes preconditioning against contractile dysfunction in the isolated blood perfused rat heart (Abstract). Circulation 90 [Suppl. I]: I-208.
6. COHEN MV, DOWNEY JM, 1993. Ischaemic preconditioning: can the protection be bottled? Lancet 342: 6.
7. COHEN MV, LIU Y DOWNEY JM, 1996. Activation of protein kinase C is critical to the protection of preconditioning. In: Parratt JR, Wainwright CL, eds, Myocardial Preconditioning. R. G. Landes, Austin, TX.
8. A) receptor-selective antagonists. J Med Chem 38: 1259-1263.
9. 1 receptor agonist was blocked by staurosporine (Abstract). J Mol Cell Cardiol 26: CLII.
10. GOTO M, LIU Y YANG X-M, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in the protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621.
11. HABUCHI Y, TANAKA H, FURUKAWA T, TSUJIMURA Y, TAKAHASHI H, YOSHIMURA M, 1992. Endothelin enhances delayed potassium current via phospholipase C in guinea pig ventricular myocytes. Am J Physiol 262: H345-H354.
12. HENDRIKX M, TOSHIMA Y MUBAGWA K, FLEMING W, 1993. Muscarinic receptor stimulation by carbachol improves functional recovery in isolated, blood perfused rabbit heart. Cardiovasc Res 27: 980-989.
13. HERBERT JM, AUGEREAU JM, GLEYE J, MAFFRAND JP, 1990. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 172: 993-999.
14. HU K, NATTEL S, 1994. Signal transduction systems underlying ischemic preconditioning in rat hearts (Abstract). Circulation 90 [Suppl. I]: I-108.
15. IKONOMIDIS JS, SHIRAI T, WEISEL RD, DERYLO B, RAO V, WHITESIDE CI, MICKLE DAG, Li R-K, 1995. "Ischemic" or adenosine preconditioning of human ventricular cardiomyocytes is protein kinase C dependent (Abstract). Circulation 92 [Suppl. I]: 1-12.
16. IRONS CE, MURRAY SF, GLEMBOTSKI CC, 1993. Identification of the receptor subtype responsible for endothelin-mediated protein kinase C activation and atrial natriuretic factor secretion from atrial myocytes. J Biol Chem 268: 23417-23421.
17. KITAKAZE M, MINAMINO T, SHINOZAKI Y, SAKAMOTO H, MORI H, KURIHARA T, HORI M, 1994. Activation of protein kinase C and subsequent activation of ectosolic 5′-nucleotidase as a major cause for the infarct size-limiting effect of ischemic preconditioning (Abstract). Circulation 90 [Suppl. I]: I-207.
18. LAWSON CS, DOWNEY JM, 1993. Preconditioning: state of the art myocardial protection. Cardiovasc Res 27: 542-550.
19. LI Y, KLONER RA, 1995. Does protein kinase C play a role in ischemic preconditioning in rat hearts? Am J Physiol 268: H426-H431.
20. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356.
21. LIU Y COHEN MV, DOWNEY JM, 1994a. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the antiinfarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 8: 881-882.
22. LIU Y YTREHUS K, DOWNEY JM, 1994b. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668.
23. LIU Y, TSUCHIDA A, COHEN MV, DOWNEY JM, 1995. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Mol Cell Cardiol 27: 883-892.
24. MASAKI T, VANE JR, VANHOUTTE PM, 1994. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol Rev 46: 137-142.
25. MILLER RC, PELTON JT, HUGGINS JP, 1993. Endothelins -from receptors to medicine. Trends Pharmacol Sci 14: 54-60.
26. MITCHELL MB, BREW EC, HARKEN AH, BANERJEE A, 1993. Does protein kinase C mediate functional preconditioning? (Abstract) J Mol Cell Cardiol 25 [Suppl. III]: S.64.
27. PRASAD MR, 1991. Endothelin stimulates degradation of phospholipids in isolated rat hearts. Biochem Biophys Res Commun 174: 952-957.
28. PRZYKLENK K, KLONER RA, 1994. Acetylcholine acts as a "preconditioning-mimetic" in the canine model (Abstract). J Am Coll Cardiol 23: 396A.
29. PRZYKLENK K, SUSSMAN MA, SIMKHOVICH BZ, KLONER RA, 1995. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation 92: 1546-1557.
30. REIMER KA, JENNINGS RB, 1985. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction. Am J Cardiol 55: 107B-115B.
31. SHUBEITA HE, MCDONOUGH PM, HARRIS AN, KNOWLTON KU, GLEMBOTSKI CC, BROWN JH, CHIEN KR, 1990. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes: a paracrine mechanism for myocardial cell hypertrophy. J Biol Chem 265: 20555-20562.
32. SPEECHLY-DICK ME, MOCANU MM, YELLON DM, 1994. Protein kinase C: its role in ischemic preconditioning in the rat. CircRes 75: 586-590.
33. THORNTON JD, DALY JF, COHEN MV, YANG X-M, DOWNEY JM, 1993a. Catecholamines can induce adenosine receptor-mediated protection of the myocardium but do not participate in ischemic preconditioning in the rabbit. Circ Res 73: 649-655.
34. THORNTON JD, LIU GS, DOWNEY JM, 1993b. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol 25: 311-320.
35. 1-selective adenosine analogues protects the heart against infarction. Circulation 85: 659-665.
36. THORNTON JD, THORNTON CS, DOWNEY JM, 1993c. Effect of adenosine receptor blockade: preventing protective preconditioning depends on time of initiation. Am J Physiol 265: H504-H508.
37. 1-Adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-585.
38. VOGT A, BARANCIK M, WEIHRAUCH D, ARRAS M, PODZUWEIT T, SCHAPERW, 1994a. Activation of protein kinase C fails to protect ischemic porcine myocardium from infarction in vivo (Abstract). J Mol Cell Cardiol 26: CXVIII.
39. VOGT A, BARANCIK M, WEIHRAUCH D, ARRAS M, PODZUWEIT T SCHAPER W, 1994b. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo (Abstract). Circulation 90 [Suppl. I]: I-647.
40. WALL TM, SHEHY R, HARTMAN JC, 1994. Role of bradykinin in myocardial preconditioning. J Pharmacol ExpTher 270: 681-689.
41. WANG Q-D, HEMSÉN A, LI X-S, LUNDBERG JM, URIUDA Y, PERNOW J, 1995. Local overflow and enhanced tissue content of endothelin following myocardial ischaemia and reperfusion in the pig: modulation by L-arginine. Cardiovasc Res 29: 44-49.
42. YANAGISAWA M, MASAKI T, 1989. Endothelin, a novel endothelium-derived peptide: pharmacological activities, regulation and possible roles in cardiovascular control. Biochem Pharmacol 38: 1877-1883.
43. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res 73: 1193-1201.
44. YOSHIDA S, DOWNEY JM, YELLON DM, MIURA T, IIMURA O, 1985. Diltiazem reduced infarct size but not ventricular arrhythmias in 48 hour coronary embolized dogs. Can J Cardiol 1: 346-353.
45. YTREHUS K, LIU Y, DOWNEY JM, 1994a. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 266: H1145-H1152.
46. YTREHUS K, LIU Y, TSUCHIDA A, MIURA T, LIU GS, YANG X-M, HERBERT D, COHEN MV, DOWNEY JM, 1994b. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol 267: H2383-H2390.